GRDN
NYSEGuardian Pharmacy Services Inc.
News25/Ratings5
Price$40.59+5.79 (+16.64%)
2026-03-042026-06-05
News · 26 weeks64-92%
2025-12-142026-06-07
Mix5290d
- Insider28(54%)
- SEC Filings13(25%)
- Other4(8%)
- Earnings3(6%)
- Offering2(4%)
- Analyst2(4%)
Latest news
25 items- SECGuardian Pharmacy Services Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
- INSIDERDirector Cosler Steven D was granted 4,028 shares, increasing direct ownership by 16% to 29,012 units (SEC Form 4)4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERDirector Lewis Randall J was granted 4,028 shares, increasing direct ownership by 36% to 15,071 units (SEC Form 4)4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERDirector Patchett Mary Sue was granted 4,028 shares, increasing direct ownership by 36% to 15,071 units (SEC Form 4)4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- SECSEC Form 8-K filed by Guardian Pharmacy Services Inc.8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
- SECSEC Form S-8 filed by Guardian Pharmacy Services Inc.S-8 - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
- SECSEC Form S-3ASR filed by Guardian Pharmacy Services Inc.S-3ASR - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
- SECSEC Form 10-Q filed by Guardian Pharmacy Services Inc.10-Q - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
- SECGuardian Pharmacy Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)
- PRGuardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year GuidanceGuardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the first quarter ended March 31, 2026. The Company also updated its full-year guidance. First Quarter Financial Results Revenue of $336.6 million, up 2% year-over-year. Residents served ended the quarter at approximately 207,000, up 10% year-over-year. Net Income of $13.5 million, compared to $9.3 million in the prior-year period. Adjusted EBITDA of $29.8 million, compared to $23.4 million in the prior-year period. Diluted EPS of $0.21 for the quarter, with Adjusted EPS of $0.29.1 Cash and cash equivalent
- SECSEC Form SCHEDULE 13G filed by Guardian Pharmacy Services Inc.SCHEDULE 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)
- ANALYSTBofA Securities initiated coverage on Guardian Pharmacy Services with a new price targetBofA Securities initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $42.00
- PRGuardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare ConferenceGuardian Pharmacy Services, Inc. (NYSE:GRDN) will be attending the Bank of America 2026 Healthcare Conference in Las Vegas on Wednesday, May 13, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 9:20 a.m. Pacific Daylight Time. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation accessible through Guardian Pharmacy Service's website at https://investors.guardianpharmacy.com. About Guardian Pharmacy Services Guardian Pharmacy Services is one of the nation's leading long-term care pharmacy services companies. Through its locally‑based business model, Guardian part
- PRGuardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference CallGuardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that it will release first quarter 2026 financial results after market close on Wednesday, May 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United States and Canada, or +1 (585) 542-9983 for international participants, and referencing conference ID "621845633." A webcast replay will be available shortly after the call's completion. About Guardian Pharmacy Services Gu
- INSIDERSEC Form 3 filed by new insider Eakins Richard3 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 3 filed by new insider Towns Douglas3 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 3 filed by new insider Mudd William Franklin3 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 3 filed by new insider Weir Robert3 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 3 filed by new insider Crisafulli Chris3 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 3 filed by new insider Tuch Jeffrey3 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 3 filed by new insider Martin David Norman3 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 4 filed by Salentine Thomas J Jr4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 4 filed by Ackerman John4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 4 filed by Burke Fred4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
- INSIDERSEC Form 4 filed by Cardinal Equity Fund, L.P.4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)
GRDN FAQ
6 questionsWhere does GRDN stock trade?
Guardian Pharmacy Services Inc. (GRDN) is listed on NYSE.What sector and industry is GRDN in?
Guardian Pharmacy Services Inc. operates in the Consumer Staples sector, Retail-Drug Stores and Proprietary Stores industry.When did Guardian Pharmacy Services Inc. go public?
Guardian Pharmacy Services Inc. (GRDN) completed its IPO in 2024.What are analysts saying about GRDN?
Guardian Pharmacy Services Inc. has had 5 recent analyst actions on file. The most recent action was from BofA Securities: Buy with a $4200.00 price target on 2026-04-27. Recent price targets range from $2100.00 to $4400.00.What companies are similar to GRDN?
Notable peers in the same industry include CVS (CVS Health Corporation), WBA (Walgreens Boots Alliance Inc.), RAD (Rite Aid Corporation), YI (111 Inc.), MDVL (MedAvail Holdings Inc.). Compare GRDN side-by-side with any of them on Quantisnow.How can I track GRDN on Quantisnow?
Quantisnow aggregates Guardian Pharmacy Services Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GRDN to receive live email and push alerts on every new disclosure.